At the upper end of the price band, the fourth largest pharmaceutical company in terms of domestic sales will be valued at ₹43,264 crore. The four-crore share IPO will be entirely an offer-for-sale (OFS) where existing shareholders will offload a portion of their stakes.
Concurrent Gainers: 13 smallcap stocks that gained for 5 days in a row
Over the five trading sessions ending August 21, the Sensex benchmark declined 0.60%, or 468 points, to close at 77,541. The index ended lower in
August 22, 2026